Clinical Trials in Chicago

Showing 2361-2380 of 17,609 trials

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

NCT04187105

This study is being done to see if the addition of a targeted form of radiation to standard conditioning regimen will increase the amount of cancer cells that are killed off in the bone marrow and reduce the chances that your disease may return. This description is called Intensity Modulated Total Marrow Irradiation (IM-TMI).

Acute LeukemiaMDS

University of Illinois at Chicago27 participantsStarted Jan 2020

Chicago, Illinois, United States

Active Not RecruitingPhase 22.2 miles

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

NCT06926842

The main purpose of this study is to investigate efficacy and safety of three doses of petrelintide versus placebo in participants with overweight or obesity and type 2 diabetes.

OverweightType 2 DiabetesObesity

Zealand Pharma221 participantsStarted Apr 2025

Cullman, Alabama, United States • Chandler, Arizona, United States • Phoenix, Arizona, United States +45 more locations

BMT-06: Study of Intensity Modulated Total Marrow Irradiation (IM-TMI)

Efficacy and Safety of Petrelintide in Participants With Overweight or Obesity and Type 2 Diabetes (ZUPREME 2)

Find Trials by Condition in Chicago

Pramipexole Versus Escitalopram to Treat Major Depressive Disorder (MDD) and Comorbid MDD With Mild Neurocognitive Disorder (MND) in Persons With HIV

A Phase III, Safety, Tolerability and Efficacy of Combination Treatment of BL-8040 and Granulocyte Colony Stimulating Factor (G-CSF) as Compared to Placebo and G-CSF for the Mobilization of Hematopoietic Stem Cells for Autologous Transplantation in Subjects With Multiple Myeloma (MM)

Sacituzumab Govitecan +/- Pembrolizumab In HR+ / HER2 - MBC

A Study of REGN7041 for Active Noninfectious Uveitis in Adult Participants

A Study Evaluating the Effect of Daily Oral RO7795081 in Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity

Bupropion to Reduce Cancer Related Fatigue in Cancer Survivors

Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears

An Open-Label Extension Study of GSK3511294 (Depemokimab) in Participants Who Were Previously Enrolled in 206713 (NCT04719832) or 213744 (NCT04718103)

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

Study of Serine Supplementation to Protect Vision in MacTel

Prostate Active Surveillance Study

Study BT7480-100 in Patients With Advanced Malignancies Associated With Nectin-4 Expression

A Study of DM005 in Patients With Advanced Solid Tumors

Immunotherapy With MK-3475 in Surgically Resectable Head and Neck Squamous Cell Carcinoma

Randomized, Open-label, Two-arms, Phase III Comparative Study Assessing the Role of Involved Mediastinal Radiotherapy After Rituximab Containing Chemotherapy Regimens to Patients With Newly Diagnosed Primary Mediastinal Large B-Cell Lymphoma

A Study of Cytisinicline for Smoking Cessation in Adult Smokers

Clinical Trial to Evaluate the Safety and Efficacy of MeRT Treatment in Post-Traumatic Stress Disorder

Phase 2 Study of SR-8541A in Combination With Botensilimab and Balstilimab in Subjects With Refractory Metastatic Microsatellite Stable Colorectal Cancer (MSS-CRC)